Sign up to save your podcasts
Or
Share AstraZeneca vaccine: Did the UK benefit from negotiating their contract early?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AstraZeneca vaccine: Did the UK benefit from negotiating their contract early?
The Oxford AstraZeneca vaccine has been a source of tension between the United Kingdom and European Union, especially concerning the number of doses each party was due to receive. The UK was able to start administering the drug much faster than the EU, but why was it able to do so? The Fact or Fake team takes a closer look.
View all episodes
By FRANCE 24 EnglishThe Oxford AstraZeneca vaccine has been a source of tension between the United Kingdom and European Union, especially concerning the number of doses each party was due to receive. The UK was able to start administering the drug much faster than the EU, but why was it able to do so? The Fact or Fake team takes a closer look.
More shows like Fact or Fake
View all
arts24
4 Listeners
People & Profit
0 Listeners
Access Asia
0 Listeners
Talking Europe
2 Listeners
Tech 24
4 Listeners
Down to Earth
0 Listeners
Business
4 Listeners
The Debate
24 Listeners
Inside the Americas
6 Listeners
Europe Rendezvous
5 Listeners
The World This Week
39 Listeners
Reporters
3 Listeners
Focus
4 Listeners
You are here
5 Listeners
Banlieue Project
1 Listeners
Eye on Africa
5 Listeners
The Observers
0 Listeners
Press Review
0 Listeners
The Observers Direct
0 Listeners